Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
3.
J Infect Dis ; 208(8): 1255-65, 2013 Oct 15.
Article in English | MEDLINE | ID: mdl-23788726

ABSTRACT

BACKGROUND: Low iron availability in the host upregulates the mbt gene cluster of Mycobacterium tuberculosis, which is responsible for mycobactin biosynthesis. However, the biological significance of mycobactins in the growth of this pathogen and in disease progression has not been elucidated. METHODS: We have disrupted the mbtE gene (Rv2380c) in the mbt cluster to evaluate the importance of mycobactin biosynthesis in the growth and virulence of M. tuberculosis. RESULTS: The mbtE mutant (MtbΔmbtE) was unable to synthesize mycobactins, displayed an altered colony morphology, and was attenuated for growth in broth culture and in macrophages. Transmission electron microscopy revealed that MtbΔmbtE displayed an altered cell wall permeability. The growth characteristics and colony morphology of MtbΔmbtE were similar to wild type when the medium was supplemented with mycobactins or when MtbΔmbtE was genetically complemented with the mbtE gene. Moreover, guinea pigs infected with MtbΔmbtE exhibited a significantly reduced bacillary load and histopathological damage in the organs, in comparison to M. tuberculosis-infected animals. CONCLUSIONS: This study highlights the importance of mycobactins in the growth and virulence of M. tuberculosis and establishes the enzymes of mycobactin biosynthesis as novel targets for the development of therapeutic interventions against tuberculosis.


Subject(s)
Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/pathogenicity , Oxazoles/metabolism , Animals , Bacterial Load , Cell Line , Female , Gene Deletion , Genes, Bacterial , Guinea Pigs , Histocytochemistry , Humans , Monocytes/microbiology , Multigene Family , Mycobacterium tuberculosis/growth & development , Statistics, Nonparametric
4.
J Bacteriol ; 194(3): 567-75, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22101841

ABSTRACT

Iron is one of the crucial elements required for the growth of Mycobacterium tuberculosis. However, excess free iron becomes toxic for the cells because it catalyzes the production of reactive oxygen radicals, leading to oxidative damage. Hence, it is essential for the pathogen to have the ability to store intracellular iron in an iron-rich environment and utilize it under iron depletion. M. tuberculosis has two iron storage proteins, namely BfrA (Rv1876; a bacterioferritin) and BfrB (Rv3841; a ferritin-like protein). However, the demonstration of biological significance requires the disruption of relevant genes and the evaluation of the resulting mutant for its ability to survive in the host and cause disease. In this study, we have disrupted bfrA and bfrB of M. tuberculosis and demonstrated that these genes are crucial for the storage and supply of iron for the growth of bacteria and to withstand oxidative stress in vitro. In addition, the bfrA bfrB double mutant (H37Rv ΔbfrA ΔbfrB) exhibited a marked reduction in its ability to survive inside human macrophages. Guinea pigs infected with H37Rv ΔbfrA ΔbfrB exhibited a marked diminution in the dissemination of the bacilli to spleen compared to that of the parental strain. Moreover, guinea pigs infected with H37Rv ΔbfrA ΔbfrB exhibited significantly reduced pathological damage in spleen and lungs compared to that of animals infected with the parental strain. Our study clearly demonstrates the importance of these iron storage proteins in the survival and pathogenesis of M. tuberculosis in the host and establishes them as attractive targets for the development of new inhibitors against mycobacterial infections.


Subject(s)
Bacterial Proteins/metabolism , Ferritins/metabolism , Macrophages/microbiology , Microbial Viability , Mycobacterium tuberculosis/metabolism , Mycobacterium tuberculosis/pathogenicity , Tuberculosis/microbiology , Animals , Bacterial Proteins/genetics , Cell Line , Disease Models, Animal , Female , Ferritins/genetics , Guinea Pigs , Humans , Iron/metabolism , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/growth & development , Virulence
5.
Vaccine ; 29(45): 8118-25, 2011 Oct 19.
Article in English | MEDLINE | ID: mdl-21856361

ABSTRACT

An efficient global control of tuberculosis requires development of alternative vaccination strategies that can enhance the efficacy of existing BCG vaccine. In this study, we evaluated the protective efficacy of a recombinant BCG (rBCG) vaccine over-expressing iron-cofactored superoxide dismutase (SOD-A), one of the prominent oxidative stress response proteins of Mycobacterium tuberculosis. Contrary to our expectations, over-expression of SOD-A resulted in the abrogation of BCG's ability to confer protection in guinea pig as well as in murine model. Analysis of immune responses revealed that over-expression of SOD-A by rBCG has pleiotropic effects on innate and adaptive immune responses. Macrophages infected in vitro with rBCG exhibited a marked reduction in apoptosis and microbicidal potential. In addition, rBCG vaccination of mice resulted in a reduced IFNγ and increased IL10 production when compared with the BCG vaccination. Further, we show that rBCG vaccination failed to generate an effective multi-functional CD4 T cell response. Altogether, our findings suggest that over-expression of SOD-A in BCG enhances the immuno-suppressive properties of BCG, characterized by skewing of immune responses towards Th2 type, an inefficient multi-functional T cell response and reduced apoptosis and microbicidal potential of macrophages leading to abolishment of BCG's protective efficacy.


Subject(s)
BCG Vaccine/immunology , Bacterial Proteins/biosynthesis , Gene Expression , Superoxide Dismutase/biosynthesis , Tuberculosis/prevention & control , Animals , Apoptosis , BCG Vaccine/administration & dosage , CD4-Positive T-Lymphocytes/immunology , Female , Guinea Pigs , Immunosuppression Therapy , Interferon-gamma/metabolism , Interleukin-10/metabolism , Macrophages/immunology , Mice , Mice, Inbred BALB C , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/immunology
6.
PLoS One ; 6(4): e18773, 2011 Apr 18.
Article in English | MEDLINE | ID: mdl-21533158

ABSTRACT

BACKGROUND: Efficient control of tuberculosis (TB) requires development of strategies that can enhance efficacy of the existing vaccine Mycobacterium bovis Bacille Calmette Guerin (BCG). To date only a few studies have explored the potential of latency-associated antigens to augment the immunogenicity of BCG. METHODS/PRINCIPAL FINDINGS: We evaluated the protective efficacy of a heterologous prime boost approach based on recombinant BCG and DNA vaccines targeting α-crystallin, a prominent latency antigen. We show that "rBCG prime-DNA boost" strategy (R/D) confers a markedly superior protection along with reduced pathology in comparison to BCG vaccination in guinea pigs (565 fold and 45 fold reduced CFU in lungs and spleen, respectively, in comparison to BCG vaccination). In addition, R/D regimen also confers enhanced protection in mice. Our results in guinea pig model show a distinct association of enhanced protection with an increased level of interleukin (IL)12 and a simultaneous increase in immuno-regulatory cytokines such as transforming growth factor (TGF)ß and IL10 in lungs. The T cell effector functions, which could not be measured in guinea pigs due to technical limitations, were characterized in mice by multi-parameter flow cytometry. We show that R/D regimen elicits a heightened multi-functional CD4 Th1 cell response leading to enhanced protection. CONCLUSIONS/SIGNIFICANCE: These results clearly indicate the superiority of α-crystallin based R/D regimen over BCG. Our observations from guinea pig studies indicate a crucial role of IL12, IL10 and TGFß in vaccine-induced protection. Further, characterization of T cell responses in mice demonstrates that protection against TB is predictable by the frequency of CD4 T cells simultaneously producing interferon (IFN)γ, tumor necrosis factor (TNF)α and IL2. We anticipate that this study will not only contribute toward the development of a superior alternative to BCG, but will also stimulate designing of TB vaccines based on latency antigens.


Subject(s)
Cytokines/metabolism , Lung/metabolism , Tuberculosis, Pulmonary/prevention & control , alpha-Crystallins/administration & dosage , Animals , BCG Vaccine/administration & dosage , Guinea Pigs , Lung/pathology , Mice , Models, Animal , Mycobacterium bovis/growth & development , Mycobacterium bovis/immunology , Tuberculosis, Pulmonary/pathology
7.
Vaccine ; 28(1): 63-70, 2009 Dec 10.
Article in English | MEDLINE | ID: mdl-19835824

ABSTRACT

Owing to its highly immunodominant nature and ability to induce long-lived memory immunity, ESAT-6, a prominent antigen of Mycobacterium tuberculosis, has been employed in several approaches to develop tuberculosis vaccines. Here, for the first time, we combined ESAT-6 based recombinant BCG (rBCG) and DNA vaccine (DNAE6) in a prime boost approach. Interestingly, in spite of inducing an enhanced antigen specific IFN-gamma response in mice, a DNAE6 booster completely obliterated the protection imparted by rBCG against tuberculosis in guinea pigs. Analysis of immunopathology and cytokine responses suggests involvement of an exaggerated immunity behind the lack of protection imparted by this regimen.


Subject(s)
Antigens, Bacterial/immunology , BCG Vaccine/immunology , Bacterial Proteins/immunology , Immunization, Secondary , Tuberculosis, Pulmonary/prevention & control , Animals , Female , Guinea Pigs , Interferon-gamma/immunology , Lung/immunology , Lung/microbiology , Lung/pathology , Mice , Mice, Inbred BALB C , Mycobacterium tuberculosis/immunology , Spleen/immunology , Spleen/microbiology , Spleen/pathology , Tuberculosis, Pulmonary/immunology , Vaccines, DNA/immunology
8.
Vaccine ; 23(48-49): 5655-65, 2005 Dec 01.
Article in English | MEDLINE | ID: mdl-16157425

ABSTRACT

DNA vaccination is an effective method for elicitation of strong humoral as well as cellular immune responses. DNA vaccines expressing mycobacterial antigens ESAT-6 (Rv3875), alpha-crystallin (Rv2031c) and superoxide dismutase A (Rv3846) were evaluated for their immune responses in Balb/c mice and protective efficacy in guinea pigs. Immunization of mice with the DNA vaccines expressing superoxide dismutase A and alpha-crystallin resulted in markedly higher levels of IFN-gamma as compared to the levels of IL-10. The DNA vaccine expressing ESAT-6 elicited a mixed Th1/Th2 response. Immunization of guinea pigs with these DNA vaccines and subsequent challenge of animals with Mycobacterium tuberculosis H(37)Rv, showed that DNA vaccine expressing superoxide dismutase imparted the maximum protection as observed by a 50 and 10 folds reduction in bacillary load in spleens and lungs, respectively, in comparison to immunization with vector control.


Subject(s)
Antigens, Bacterial/immunology , Mycobacterium tuberculosis/genetics , Tuberculosis/prevention & control , Vaccines, DNA/administration & dosage , Animals , Antibodies, Bacterial/biosynthesis , COS Cells , Chlorocebus aethiops , Guinea Pigs , Lung/pathology , Mice , Mice, Inbred BALB C , Mycobacterium tuberculosis/immunology , Tuberculosis/immunology , Vaccines, DNA/immunology
9.
Mol Microbiol ; 50(3): 751-62, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14617138

ABSTRACT

Protein tyrosine kinases and tyrosine phosphatases from several bacterial pathogens have been shown to act as virulence factors by modulating the phosphorylation and dephosphorylation of host proteins. The identification and characterization of two tyrosine phosphatases namely MptpA and MptpB from Mycobacterium tuberculosis has been reported earlier. MptpB is secreted by M. tuberculosis into extracellular mileu and exhibits a pH optimum of 5.6, similar to the pH of the lysosomal compartment of the cell. To determine the role of MptpB in the pathogenesis of M. tuberculosis, we constructed a mptpB mutant strain by homologous recombination and compared the ability of parent and the mutant strain to survive intracellularly. We show that disruption of the mptpB gene impairs the ability of the mutant strain to survive in activated macrophages and guinea pigs but not in resting macrophages suggesting the importance of its role in the host-pathogen interaction. Infection of guinea pigs with the mutant strain resulted in a 70-fold reduction in the bacillary load of spleens in infected animals as compared with the bacillary load in animals infected with the parental strain. Upon reintroduction of the mptpB gene into the mutant strain, the complemented strain was able to establish infection and survive in guinea pigs at rates comparable to the parental strain. These observations demonstrate a role of MptpB in the pathogenesis of M. tuberculosis.


Subject(s)
Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Mycobacterium tuberculosis/pathogenicity , Protein Tyrosine Phosphatases/genetics , Protein Tyrosine Phosphatases/metabolism , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Animals , Cells, Cultured , Genetic Complementation Test , Guinea Pigs , Host-Parasite Interactions/genetics , Macrophages/microbiology , Mice , Mutation , Mycobacterium tuberculosis/genetics , Recombination, Genetic , Spleen/microbiology , Spleen/pathology , Tuberculosis/microbiology , Tuberculosis/pathology , Virulence/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...